FrederickTMurphyDOFACP,FACR

Rheumatology • Duncansville, PA

Adjunct Clinical Assistant Professor of Medicine University of Pennsylvania 2001-2014

Join to view full profile

Dr. Murphy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Murphy's full profile

Already have an account?

Office
175 Meadowbrook Ln
Duncansville, PA 16635
Phone+1 814-693-0300

Education & Training

National Capital ConsortiumFellowship, 1996 - 1998
National Capital ConsortiumResidency, 1993 - 1996
Philadelphia College of Osteopathic MedicineClass of 1993

Certifications & Licensure

PA State License 2000 - 2026
VA State License 1996 - 2000
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Patients Choice Award 2009

Clinical Trials

Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2002 Sep 01
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery Start of enrollment: 2006 Apr 24
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Start of enrollment: 2005 Sep 06
Active, not recruiting
Phase 3
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer Start of enrollment: 2014 Jan 22
Active, not recruiting
Phase 3
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer Start of enrollment: 2004 Feb 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

17 citations
Efficacy and Safety of Intravenous Golimumab Through One Year in Patients With Active Psoriatic Arthritis.
M. Elaine Husni, Arthur Kavanaugh, Frederick T Murphy, Dmytro Rekalov, Diane D. Harrison
Arthritis Care & Research. 2020-06-01
43 citations
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the mult...
Josef S Smolen, Jonathan Kay, Mittie K. Doyle, Robert Landewé, Eric L. Matteson
Arthritis Research & Therapy. 2015-01-22
28 citations
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.
Lynn R. Webster, John F. Peppin, Frederick T. Murphy, Biao Lu, Jeffrey Tobias
Diabetes Research and Clinical Practice. 2011-08-01

Professional Memberships

American College of Physicians - ACP
Fellow
American College of Rheumatology - ACR
Fellow

External Links

enspice children’s foundation http://www.enspice.org
enspicehttp://www.enspice.com